Found 140 results[ Author] Title Type Year
Filters: First Letter Of Last Name is G [Clear All Filters]
Developing Materials for Transplant Centers to Share BMT CTN Clinical Trial Results with their Patients: A Pilot Study (Poster). In NCI ASCO Cancer Trials Accrual Symposium. presented at the 2010, Bethesda, MD. Retrieved from http://university.asco.org/CT2010. (2010).
Lessons from IAVI-006, a phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers. Vaccine, 26(51), 6671-7. presented at the 2008 Dec 02. doi:10.1016/j.vaccine.2008.09.016. (2008).
Loss to Follow-Up from HIV Screening to ART Initiation in Rural China. PLoS One, 11(10), e0164346. presented at the 2016. doi:10.1371/journal.pone.0164346. (2016).
Validation of the TAPS-1: A Four-Item Screening Tool to Identify Unhealthy Substance Use in Primary Care. J Gen Intern Med, 32(9), 990-996. presented at the 2017 Sep. doi:10.1007/s11606-017-4079-x. (2017).
SCORE Study Report 5: A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid f. Archives of Ophthalmology, 127, 1101-1114. presented at the 2009.. (2009).
Effect of Ruboxistaurin on Visual Loss in Patients With Diabetic Retinopathy. Ophthalmology, 113, 2221-2230. presented at the 12/2006. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/16989901. (2006).
The Age-Related Eye Disease Study: A clinical trial of zinc and antioxidants - Age-Related Eye Disease Study Report No. 2. J Nutrition, 130, 1516S-19S. presented at the 2000.. (2000).
Secondary Analyses of the Effects of Lutein/Zeaxanthin on Age-Related Macular Degeneration Progression: AREDS 2 Report Number 3. JAMA Ophthalmol, 132, 142-149. presented at the 02/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24310343. (2014).
The age-related eye disease study (AREDS) system for classifying cataracts from photographs: AREDS report no. 4. Am J Ophthalmol, 131(2), 167-75. presented at the 2001 Feb. doi:10.1016/s0002-9394(00)00732-7. (2001).
Palivizumab prophylaxis of respiratory syncytial virus (RSV) - results from the 2000-2001 Synagis Outcomes Registry. Pediatr Pulmonol, 35, 484-9. presented at the 2003.. (2003).
The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: The Age-Related Eye Disease Study Report Number 6. Am J Ophthalmol, 132, 668-81. presented at the 2001.. (2001).
The Effect of Ruboxistaurin on Visual Loss in Patients with Moderately Severe To Very Severe Nonproliferative Diabetic Retinopathy: Initial Results of The Protein Kinase C Beta Inhibitor Diabetic Retinopathy Study (PKC-DRS) Multicenter Randomized Clinical. Diabetes, 54, 2188-2197. presented at the 07/2005. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/15983221. (2005).
Design implications. AREDS Report No. 1. Control Clin Trials, 20, 573-600. presented at the 1999.. (1999).
Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. Ophthalmology, 107(12), 2224-32. presented at the 2000 Dec. doi:10.1016/s0161-6420(00)00409-7. (2000).
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. Age-Related Eye Disease Study Report No. 8. Archives of Ophthalmology, 119, 1417-1436. presented at the 2001.. (2001).
Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomized controlled trial 1: Primary outcomes. Pediatrics, 105, 295-310. presented at the 2000.. (2000).
Randomized Trial of a Home Monitoring System for Early Detection of Choroidal Neovascularization Home Monitoring of the Eye (HOME) Study. Ophthalmology, 121, 535-534. presented at the 02/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24211172. (2014).
The Age-Related Eye Disease Study 2 (AREDS2): Study Design and Baseline Characteristics (AREDS2 Report No. 1). Ophthalmology, 119, 2282-2289. presented at the 11/2012. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22840421. (2012).
The Age-Related Eye Disease Study: a clinical trial of zinc and antioxidants--Age-Related Eye Disease Study Report No. 2. J Nutr, 130(5S Suppl), 1516S-9S. presented at the 2000 05. doi:10.1093/jn/130.5.1516S. (2000).
The Age-Related Eye Disease Study (AREDS) system for classifying cataracts from photographs: AREDS Report No. 4. Am J Ophthalmol, 131, 167-75. presented at the 2001.. (2001).
The Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1. Control Clin Trials, 20(6), 573-600. presented at the 1999 Dec. doi:10.1016/s0197-2456(99)00031-8. (1999).
AREDS Update I: The effect of cataract surgery on progression to advanced AMD. presented at the 2003.. (2003).
Waiting list mortality for pediatric patients with chronic liver disease. presented at the 1998.. (1998).